Literature DB >> 9048856

Medical therapy, calcium oxalate urolithiasis.

L A Ruml1, M S Pearle, C Y Pak.   

Abstract

The development of diagnostic protocols that identify specific risk factors for calcium oxalate nephrolithiasis has led to the formulation of directed medical regimens that are aimed at correcting the underlying metabolic disturbances. Initiation of these treatment programs has reduced markedly the rate of stone formation in the majority of patients who form stones. This article discusses the rationale that underlies the choice of medical therapy for the various pathophysiologic causes of calcium oxalate nephrolithiasis and the appropriate use of available medications.

Entities:  

Keywords:  NASA Discipline Number 18-10; NASA Discipline Regulatory Physiology; NASA Program Space Physiology and Countermeasures; Non-NASA Center

Mesh:

Substances:

Year:  1997        PMID: 9048856     DOI: 10.1016/s0094-0143(05)70358-x

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  9 in total

Review 1.  Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily.

Authors:  J M Dunwell; S Khuri; P J Gane
Journal:  Microbiol Mol Biol Rev       Date:  2000-03       Impact factor: 11.056

2.  The influence of a low protein diet in idiopathic hypercalciuria.

Authors:  E N Liatsikos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

3.  Parsley! Mechanism as antiurolithiasis remedy.

Authors:  Fayed Al-Yousofy; Hussein Gumaih; Hassan Ibrahim; Afrah Alasbahy
Journal:  Am J Clin Exp Urol       Date:  2017-11-09

4.  Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Authors:  Nancy S Krieger; John R Asplin; Kevin K Frick; Ignacio Granja; Christopher D Culbertson; Adeline Ng; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

5.  Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date?

Authors:  David S Goldfarb
Journal:  Rev Urol       Date:  2002

6.  Evidence for durable kidney stone prevention over several decades.

Authors:  Joan H Parks; Fredric L Coe
Journal:  BJU Int       Date:  2008-11-18       Impact factor: 5.588

7.  Prospective randomized clinical trial comparing phytotherapy with potassium citrate in management of minimal burden (≤8 mm) nephrolithiasis.

Authors:  Iqbal Singh; Ishu Bishnoi; Vivek Agarwal; Shuchi Bhatt
Journal:  Urol Ann       Date:  2011-05

8.  Protocol-based metabolic evaluation in high-risk patients with renal stones in North India.

Authors:  Sandeep Julka; Sushil Kumar Gupta; Aneesh Srivastava
Journal:  Indian J Endocrinol Metab       Date:  2012-03

9.  Antiurolithiatic activity of ethanol leaf extract of Ipomoea eriocarpa against ethylene glycol-induced urolithiasis in male Wistar rats.

Authors:  Moonjit Das; Himaja Malipeddi
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.